Literature DB >> 10553712

Fluoroquinolone treatment of skin and skin structure infections.

A W Karchmer1.   

Abstract

When the causative pathogens are susceptible, the fluoroquinolones have been demonstrated to be highly efficacious in the treatment of both mild uncomplicated skin and skin structure infections as well as the more severe complicated infections involving these tissues, including infections of the feet of diabetic patients. These broad spectrum agents, particularly the newer fluoroquinolones with enhanced activity against gram-positive bacteria, are ideal for treating the often polymicrobial complicated skin and skin structure infections. The wisdom of treating uncomplicated skin infections, which are primarily due to staphylococci and streptococci wherein more narrow spectrum beta-lactam antibiotics would suffice, is questionable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553712     DOI: 10.2165/00003495-199958002-00016

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  14 in total

1.  Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.

Authors:  L O Gentry; C H Ramirez-Ronda; E Rodriguez-Noriega; H Thadepalli; P L del Rosal; C Ramirez
Journal:  Arch Intern Med       Date:  1989-11

2.  Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.

Authors:  R J Fass; J F Plouffe; J A Russell
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

3.  Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections.

Authors:  D M Citron; M D Appleman
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

4.  Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.

Authors:  H Tassler
Journal:  Am J Med       Date:  1993-03-22       Impact factor: 4.965

5.  Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.

Authors:  R D Powers
Journal:  Am J Med       Date:  1993-03-22       Impact factor: 4.965

Review 6.  Assessment and management of foot disease in patients with diabetes.

Authors:  G M Caputo; P R Cavanagh; J S Ulbrecht; G W Gibbons; A W Karchmer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

7.  Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy.

Authors:  D M Bamberger; G P Daus; D N Gerding
Journal:  Am J Med       Date:  1987-10       Impact factor: 4.965

8.  A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.

Authors:  L O Gentry; G Rodriguez-Gomez; B J Zeluff; A Khoshdel; M Price
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

9.  Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.

Authors:  M L Grayson; G W Gibbons; G M Habershaw; D V Freeman; F B Pomposelli; B I Rosenblum; E Levin; A W Karchmer
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

10.  Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both.

Authors:  L R Peterson; L M Lissack; K Canter; C E Fasching; C Clabots; D N Gerding
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

View more
  5 in total

1.  Are Respiratory Quinolones Useful for the Treatment of Skin and Soft Tissue Infections?

Authors:  James S. Tan
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

2.  Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.

Authors:  G Siami; N Christou; I Eiseman; K J Tack
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 3.  Moxifloxacin in uncomplicated skin and skin structure infections.

Authors:  Richard B R Muijsers; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Staphylococcal skin infections in children: rational drug therapy recommendations.

Authors:  Shamez Ladhani; Mehdi Garbash
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  The Role of Fluoroquinolones in the Treatment of Skin and Soft Tissue Infection.

Authors:  Md Rabiul Alam; Ellie Hershberger; Marcus J. Zervos
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.